Asthma Spacers Market By Product (Aerochamber, Inspirease, Optichamber and Volumatic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and E-Commerce) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The asthma spacers market is expected to grow at a compound annual growth rate (CAGR) of 3.8% between 2018 and 2026, from US$ 1,311.1 million in 2017 to US$ 1,824.4 million by 2026. As per the latest research citations of the World Health Organization (WHO), approximately 235 million people worldwide are suffering from asthma, and by 2025, an additional increase of 100 million is expected. Asthma spacers are beneficial in mitigating dosing discrepancies associated with inhalers and nebulizers.

Technological advancement and the excellent control and coordination obtained while using metered dose inhalers increase the popularity of aerosols.

Aerochamber is reigning in the product segment of the market for asthma spacers. The latest technological advancements and excellent control and coordination achieved by patients while using metered dose inhalers drive the aerosolizer market's growth. It has a greater adoption rate as it is available in different mask sizes to fit patients belonging to different age groups. Inspiration has gained acknowledgment in recent years as it is beneficial in increasing the distance between the MDI and mouth, thereby lowering the inhalation of propellants in the oropharyngeal region.

The establishment of premium medicines, as well as a significant increase in the launch of professionalized pharmacy chains, will propel retail pharmacy market growth.

Retail pharmacy is dominating the distribution channel segment for the asthma spacer market. The establishment of premium medicine and a significant rise in the number of pharmacy chains worldwide will provide a positive impetus to the retail pharmacy market's growth. Increasing demand for metered-dose inhalers has led to a rise in over-the-counter (OTC) sales of asthma spacers in retail pharmacies. E-commerce will capture the market during the forecast period owing to the availability of low-priced asthma spacers in comparison to retail stores due to low overhead costs. Domestic and international vendors exhibit their products online, which provides more options to consumers. Increasing adoption of digital products by consumers facilitates the e-commerce market's growth.

The rising prevalence of asthma, as well as the location of key players, drive the growth of the asthma spacers market.

In the present scenario, with a 34% market share, North America is the largest regional segment for the asthma spacer market. According to Center for Disease Control and Prevention (CDC) statistics from 2017, the percentage of children under 18 years of age suffering from asthma was 8.4%. Asthma spacers market growth in North America is being driven by rising asthma prevalence and the presence of key players such as Allergan, Inc., CONMED Corporation, Trudell Medical International, and others. Europe is in the second position with a 26% market share, primarily due to the supportive regulatory environment provided by the European Medical Agency (EMA) for the manufacturing and sale of asthma spacers. Asia Pacific represents 16% market growth and will garner stable growth in the near future due to the rising prevalence of respiratory disorders and a well-established e-commerce sector.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by product, distribution channel, and geography.

Medical device manufacturers producing asthma spacers are AstraZeneca, Plc., Allergan, Inc., CONMED Corporation, Clement Clarke International Limited, GlaxoSmithKline, Plc., Koninklijke Philips N.V., Medical Developments International, Merck & Co., Inc., PARI Respiratory Equipment, Inc., and Trudell Medical International.

Key questions are answered in this report.

  • Who are the major players actively engaged in the asthma spacer market?
  • What are the drivers, opportunities, and limitations associated with the asthma spacer market?
  • What is the disease etiology associated with asthma, and what are the problems encountered in the drug dosing of metered-dose inhalers?
  • What will be the market size and CAGR of aero chambers during the forecast period?
  • What will be the market performance of the e-commerce sector in the near future?
  • What is the asthma prevalence rate in North America for the market for asthma spacers?

Frequently Asked Questions:

The market for Asthma Spacers Market is expected to reach US$ 1,824.4 Mn by 2026.

The Asthma Spacers Market is expected to see significant CAGR growth over the coming years, at 3.8%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Allergan, Inc., CONMED Corporation, Clement Clarke International Limited, GlaxoSmithKline, Plc., Koninklijke Philips N.V., Medical Developments International, Merck & Co., Inc are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Mar 2019
Category:  Medical Devices
Report ID:   59628
Report Format:   PDF
Pages:   120
Rating:    4.2 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support